Partially unspliced and fully spliced ELF3 mRNA, including a new Alu element in human breast cancer

Breast Cancer Research and Treatment

Volumn 83, Issue 2, 2004, Pages 171-187

  Kaplan, Mark H ^a   Wang, Xue Ping ^a   Xu, Hao Peng ^a   Dosik, Michael H ^b  

^a NORTH SHORE UNIVERSITY HOSPITAL   (United States)

^b N Shore Hematol/Oncol Associates   (United States)

Author keywords

Alu element; Breast cancer cells; ELF3; Intron retention; Unspliced mRNA

Indexed keywords

COMPLEMENTARY DNA; DEOXYRIBONUCLEASE; DNA FRAGMENT; HELIX LOOP HELIX PROTEIN; RIBONUCLEASE; TRANSCRIPTION FACTOR ELF3; UNCLASSIFIED DRUG;

ALU SEQUENCE; ARTICLE; BREAST CANCER; CANCER TISSUE; CELL NUCLEUS; CONTROLLED STUDY; CYTOPLASM; DNA DETERMINATION; DNA ISOLATION; DNA SEQUENCE; ENZYMATIC DEGRADATION; EXON; GENE AMPLIFICATION; GENE EXPRESSION; GENE MUTATION; GENE TECHNOLOGY; GENETIC CODE; GENETIC PROCEDURES; GENOME ANALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRON; MULTIGENE FAMILY; NORTHERN BLOTTING; NUCLEIC ACID PROBE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RAPID AMPLIFICATION OF CDNA END; RNA SPLICING; SEQUENCE HOMOLOGY;

ALU ELEMENTS; BASE SEQUENCE; BLOTTING, NORTHERN; BREAST; BREAST NEOPLASMS; DNA PRIMERS; DNA-BINDING PROTEINS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MOLECULAR SEQUENCE DATA; PROTO-ONCOGENE PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTION FACTORS;

EID: 0742304064     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:BREA.0000010710.51614.2d     Document Type: Article

References (49)

1. Lisitsyn N, Lisitsyn N, Wigler M: Cloning the difference between two complex genomes. Science 259: 946-951, 1993
2. Hubank M, Schatz DG: Identifying differences in mRNA expression by representational difference analysis of cDNA. Nucleic Acids Res 22: 5640-5648, 1994
3. Lisitsyn NA, Lisistina NM, Dalbagni G, Barker P, Sanchez CA, Gnarra J, Linehan WM, Reid BJ, Wigler MH: Comparative genomic analysis of tumors: detection of DNA losses and amplification. Proc Natl Acd Sci USA 92: 151-155, 1995
4. Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles MD, Moore PS: Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266: 1865-1869, 1994
5. Nishizawa T, Okamoto H, Konishi K, Yoshizawa H, Miyakawa Y, Mayumi M: A novel DNA virus (TTV) associated with elevated transaminase levels in posttransfusion hepatitis of unknown etiology. Biochem Biophys Commun 24: 92-97, 1997
6. Yuan L, Shan J, De Risi D, Broome J, Lovecchio J, Gal D, Vinciguerra V, Xu HP: Isolation of a novel gene, TSP50, by a hypomethylated DNA fragment in human breast cancer. Cancer Res 59: 3215-3221, 1999
7. Chang C-H, Scott GK, Kuo W-L, Xiong X, Suzdaltseva Y, Park JW, Sayre P, Erny K, Collins C, Gray JW, Benz CC: ESX: A structurally unique Ets overexpressed early during human breast tumorigenesis. Oncogene 14: 1617-1622, 1997
8. Oettgen P, Alani RM, Barcinski MA, Brown L, Akbarali Y, Boltax J, Kunsch C, Munger K, Liberman TA: Isolation and characterization of a novel epithelium specific transcription factor, ESE-1, a member of the ets family. Mol Cell Biol 17: 4419-4433, 1997
9. Tymms MJ, Ng AYN, Thomas RS, Schutte BC, Zhou J, Eyre HJ, Sutherland GR, Seth A, Rosenberg M, Papas T, Debouck C, Kola I: A novel epithelial-expressed ETS gene, ELF3: human and murine cDNA sequences, murine genomic organization, human mapping to 1q32.2 and expression in tissues and cancer. Oncogene 15: 2449-2462, 1997
10. Andreoli JM, Jang SI, Chung E, Coticchia CM, Steinert PM, Markova NG: The expression of a novel, epithelial-specific ets transcription factor is restricted to the most differentiated layers in the epidermis. Nucleic Acids Res 25: 4287-4295, 1997
11. Choi SG, Yi Y, Kim YS, Kato M, Chang J, Chung H-W, Hahm K-B, Yang H-K, Rhee HH, Bang Y-J, Kim S-J: A novel ets-related transcription factor, ERT/ESX/ESE-1, regulates expression of the transforming growth factor-beta type II receptor. J Biol Chem 273: 110-117, 1998
12. Chang C-H, Scott GK, Baldwin MA, Benz CC: Exon 4-encoded acidic domain in the epithelium-restricted Ets factor, ESX, confers potent transactivating capacity and binds to TATA-binding protein (TBP). Oncogene 18: 3682-3695, 1999
13. Oettgen P, Barcinski M, Boltax J, Stolt P, Akbarali Y, Libermann TA: Genomic organization of the human ELF3 (ESE-1/ESX) gene, a member of the Ets transcription factor family, and identification of a functional promotor. Genomics 55: 358-362, 1999
14. Oettgen P, Carter KC, Augustus M, Barcinski M, Boltax J, Kunsch C, Libermann TA: The novel epithelial-specific Ets transcription factor gene ESX maps to human chromosome 1q32.1. Genomics 45: 456-457, 1997
15. Brembeck FH, Opitz OG, Libermann TA, Rustgi AK: Dual function of the epithelial specific ets transcription factor, ELF3, in modulating differentiation. Oncogene 19: 1941-1949, 2000
16. Darnell J, Lodish H, Baltimore D: RNA synthesis and processing in eukaryotes. In: Molecular Cell Biology. 2nd edn, Chapter 8, Scientific American Books Inc, pp 261-313
17. Cramer P, Srebrow A, Kadener S, Werbajh S, De La Mata M, Melen G, Nogues G, Kornblihtt AR: Coordination between transcription and pre-mRNA processing. FESE Lett 498: 179-182, 2001
18. Hide WA, Babenko VN, van Heusden PA, Seoighe C, Kelso JF: The contribution of exon-skipping events on chromosome 22 to protein coding diversity. Genome Res 11: 1848-1853, 2001
19. Stutz F, Rosbash M: Nuclear RNA export. Genes Dev 12: 3303-3319, 1998
20. Krug RM: The regulation of export of mRNA from nucleus to cytoplasm. Curr Opin Cell Biol 5: 944-949, 1993
21. Hastings ML, Krainer AR: Pre-mRNA splicing in the new millennium. Curr Opin Cell Biol (United States) 13: 302-309, 2001
22. Gazdar AF, Kurvari V, Virmani A, Gollahon L, Sakaguchi M, Westerfield M, Kodagoda D, Stasny V, Cunningham HT, Wistuba II, Tomlinson G, Tonk V, Ashfaq R, Leitch AM, Minna JD, Shay JW: Characterization of paired tumor and non-tumor cell lines established from patients with breast cancer. Int J Cancer 78: 766-774, 1998
23. Don RH, Cox PT, Wainwright BJ, Baker K, Mattick JS: 'Touchdown' PCR to circumvent spurious priming during gene amplification. Nucleic Acids Res 19: 4008, 1995
24. Roux KH: Optimization and troubleshooting in PCR. PCR Methods Appl 4: 5185-5195, 1995
25. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ: Basic local alignment search tool. J Mol Biol 215: 403-410, 1990
26. Gish W, States DJ: Identification of protein coding regions by database similarity search. Nature Genet 3: 266-272, 1993
27. Altschul SF, Madden TL, Schäffer AA, Zhang J, Zhang Z, Miller W, Lipman DJ: Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 25: 3389-3402, 1997
28. Chang J, Lee C, Hahm K-B, Youngsuk Y, Choi S-G, Kim S-J: Over-expression of ERT (ESX/ESE/ELF3), an ets-related transcription factor, induces endogenous TGF-β signaling pathway in Hs578t human breast cancer cells. Oncogene 19: 151-154, 2000
29. Barnes DM, Bartkova J, Camplejohn RS, Gullick WJ, Smith PJ, Millis RR: Overexpression of the c-erbB-2 oncoprotein: why does this occur more frequently in ductal carcinoma in situ than in invasive mammary carcinoma and is this of prognostic significance? Eur J Cancer 28: 644-648, 1992
30. Kim J-H, Wilder PJ, Hou J, Nowling T, Rizzino A: Activation of the murine type II transforming growth factor-β receptor gene. J Biol Chem 277: 17520-17530, 2002
31. Ma Y, Koza-Taylor PH, DiMattia DA, Hames L, Haoning F, Dragnev KH, Turi T, Beebe JS, Freemantle SJ, Dmitrovsky E: Microarray analysis uncovers retinoid targets in human bronchial epithelial cells: Oncogene 22: 4924-4932, 2003
32. Raynor M, Stephenson S-A, Walsh DCA, Pittman KB, Dobrovic A: Optimisation of the RT-PCR detection of immunomagnetically enriched carcinoma cells BMC. Cancer 2: 1-14, 2002
33. Stella A, Wagner A, Shito K, Lipkin SM, Watson P, Guanti G, Lynch HT, Fodde R, Liu BA: Nonsense mutation in MLH1 causes exon skipping in three unrelated HNPCC families. Cancer Res 61: 7020-7024, 2001
34. Hellwinkel OJ-C, Holterhus P-M, Struve D, Marschke C, Homburg N, Hiort O: A unique exonic splicing mutation in the human androgen receptor gene indicates a physiologic relevance of regular androgen receptor transcript variants. J Clin Endocrinol Metab 86: 2569-2575, 2001
35. Beghini A, Ripamonti CB, Peterlongo P, Roversi G, Cairoli R, Morra E, Larizza L: RNA hyperediting and alternative splicing of hematopoietic cell phosphatase (PTPN6) gene in acute myeloid leukemia. Hum Mol Genet 22: 2297-2304, 2000
36. Matsumoto K, Wassarman KM, Wolffe AP: Nuclear history of a pre-mRNA determines the translational activity of cytoplasmic mRNA. EMBO J 17: 2107-2121, 1998
37. Nakai K, Sakamoto H: Construction of a novel database containing aberrant splicing mutations of mammalian genes. Gene 14: 171-177, 1994
38. Guldberg P, thor Straten P, Ahrenkiel V, Seremet T, Kirkin AF, Zeuthen J: Somatic mutation of the Peutz-Jeghers syndrome gene, LKB1/STK11, in malignant melanoma. Oncogene 18: 1777-1780, 1999
39. Cooper DL: Retention of CD44 introns in bladder cancer: understanding the alternative splicing of pre-mRNA opens new insights into the pathogenesis of human cancers. J Path 177: 1-3, 1995
40. Matsumura Y, Sugiyama M, Matsumura S, Hayle AJ, Robinson P, Smith JC, Tarin D: Unusual retention of introns in CD44 gene transcripts in bladder cancer provides new diagnostic and clinical oncological opportunities. J Path 177: 11-20, 1995
41. Goodison S, Yoshida K, Churchman M, Tarin D: Multiple intron rentention occurs in tumor cell CD44 mRNA processing. Am J Pathol 153: 1221-1228, 1998
42. Yoshida K, Bolodeoku J, Sugino T, Goodison S, Matsumura Y, Warren BF, Toge T, Tahara E, Tarin D: Abnormal retention of intron 9 in CD44 gene transcripts in human gastrointestinal tumors. Cancer Res 55: 4273-4277, 1995
43. Schmid CW: Does SINE evolution preclude Alu function? Nucleic Acid Res 26: 4541-4550, 2000
44. Szmulewicz MN, Novick GE, Herrera RJ: Effects of Alu insertions on gene function. Electrophoresis 19: 1260-1264, 1998
45. Piedrafita FJ, Molander RB, Vansant G, Orlova EA, Pfahl M, Reynolds WF: An Alu element in the myeloperoxidase promotor contains a composite SP1-thyroid hormone-retinoic acid response element. J Biol Chem 271: 14412-14420, 1996
46. Vansan G, Reynolds WF: The consensus sequence of a major Alu subfamily contains a functional retinoic acid response element. Proc Natl Acad Sci USA 92: 8229-8233, 1995
47. Rohlfs EM, Puget N, Graham ML, Weber BL, Garber JE, Skrzynia C, Halperin JL, Lenoir GM, Silverman LM, Mazoyer S: An Alu-mediated 7.1 kb deletion of BRCA1 exons 8 and 9 in breast and ovarian cancer families that results in alternative splicing of exon 10. Genes Chromosomes Cancer 28: 300-307, 2000
48. Cullen BR: Retroviruses as model systems for the study of nuclear RNA export pathways. Virology 249: 203-210, 1998
49. Flint SJ, Enquist LW, Krug RM, Racaniello VR, Skalka AM: Processing of viral pre-mRNA. In: Principles of Virology: Molecular Biology, Pathogenesis and Control, Chapter 10, ASM Press, Washington DC, 2000, pp 353-358